Analysis of distinct genomic, transcriptomic, and immune landscapes driven by alterations in androgen production, uptake, and conversion (APUC) genes in metastatic prostate cancers.
Kristine Peregrino Lacuna(Memorial Sloan Kettering Cancer Center), Charles J. Ryan(University of Minnesota), Ella Boytim(University of Minnesota), Wassim Abida(Memorial Sloan Kettering Cancer Center), Emmanuel S. Antonarakis(University of Minnesota), Khalid Ishani(University of Minnesota), Michael J. Morris(Memorial Sloan Kettering Cancer Center), Justin H. Hwang(University of Minnesota)
Cited by 0
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k